Clinical Trials Directory

Trials / Completed

CompletedNCT01720498

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation Under Propofol-remifentanil Anesthesia in Elderly Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Severance Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

To find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in elderly patients

Detailed description

The increase of Corrected QT (QTc) interval is associated with age. It is known that most inhalation anesthetics or intravenous anesthetics can influence the QTc. In addition, tracheal intubation during induction can stimulates sympathetic activity, which, as a results, prolong the QTc interval. Therefore, the aim of study is to find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in elderly patients.

Conditions

Interventions

TypeNameDescription
DRUGremifentanilThe effect site concentration of remifentanil

Timeline

Start date
2012-10-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2012-11-02
Last updated
2013-06-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01720498. Inclusion in this directory is not an endorsement.